Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
20 Results for "
Streptococcus faecalis
" in MedChemExpress (MCE) Product Catalog:
Products (20)
20 Results for "Streptococcus faecalis" in MCE Product Catalog:
8
Cat. No.: HY-N10264
CAS No.: 269741-97-1
Synonyms: (+)-Avrainvillamide; CJ-17,665
Category:
Infection Alkaloids Microorganisms Pyrrole Alkaloids Disease Research Fields Indole Alkaloids
Target:
Cat. No.: HY-N13668
CAS No.: 468757-69-9
Target:
Cat. No.: HY-W587957
CAS No.: 5143-05-5
Gypsogenic acid is a triterpenoid acid that can be isolated from Miconia stenostachya and has antibacterial and trypanoidal activities. The MICs values of Gypsogenic acid for the oral bacterial pathogens Enterococcus faecalis, Streptococcus salivarius, Streptococcus haematococcus, Streptococcus mutans and sobrinus were 50-200 μg/mL. Gypsogenic acid can induce blood cortensite cleavage in isolated mice with IC50 56.6 μM .
Cat. No.: HY-P10996
Synonyms: Human Neutrophil Peptide-4 TFA
Cat. No.: HY-178952
Anti-infective agent 12 (Compound A09) is a competitive inhibitor of type I signal peptidease (SPase I), with an IC50 of 4.475 μM and a Kd of 16.3 μM. Anti-infective agent 12 has the ability to disrupt bacterial membranes and remove biofilms. Anti-infective agent 12 exhibits potent bactericidal activity against Gram-positive bacteria, with MIC values of 4, 4, 8, and 8 μg/mL for Staphylococcus aureus, Enterococcus faecalis, Enterococcus faecium, and Streptococcus suis, respectively. Anti-infective agent 12 remains effective against multi-drug resistant strains, but has weaker activity against Gram-negative bacteria (such as Escherichia coli and Salmonella), with MIC values > 64 μg/mL. Anti-infective agent 12 has low hemolytic activity and shows significant efficacy in mouse skin infection models .
Cat. No.: HY-E70939
Target:
Research Areas:
L-Phenylalanine decarboxylase, Streptococcus faecalis (EC 4.1.1.53) belongs to the lyase family and is capable of cleaving carbon-carbon bonds. L-Phenylalanine decarboxylase, Streptococcus faecalis is involved in the metabolism of phenylalanine. This enzyme has one substrate, L-phenylalanine, and two products: phenylethylamine and CO2.
Cat. No.: HY-N14367
CAS No.: 50355-67-4
Category:
Target:
Cat. No.: HY-126806
CAS No.: 88912-57-6
Target:
Research Areas:
Pyrrofolic acid is a folate antagonist with a low activity as a folate antagonist for Streptococcus faecalis .
Cat. No.: HY-P2825A
Target:
Research Areas:
L-Tyrosine Decarboxylase, Streptococcus faecalis (EC 4.1.1.25), is a carboxyl lyase capable of cleaving carbon-carbon bonds. L-Tyrosine Decarboxylase Apoenzyme participates in tyrosine metabolism and alkaloid biosynthesis. L-Tyrosine Decarboxylase Apoenzyme uses a cofactor—pyridoxal phosphate. L-Tyrosine Decarboxylase Apoenzyme has one substrate, L-tyrosine, and two products: tyramine and carbon dioxide.
Cat. No.: HY-E70938
Target:
Research Areas:
L-Tyrosine Decarboxylase Apoenzyme, Streptococcus faecalis (EC 4.1.1.25), is a carboxyl lyase capable of cleaving carbon-carbon bonds. L-Tyrosine Decarboxylase Apoenzyme participates in tyrosine metabolism and alkaloid biosynthesis. L-Tyrosine Decarboxylase Apoenzyme uses a cofactor—pyridoxal phosphate. L-Tyrosine Decarboxylase Apoenzyme has one substrate, L-tyrosine, and two products: tyramine and carbon dioxide.
Cat. No.: HY-N5184
CAS No.: 256230-47-4
Synonyms: Nocathiacine III
Category:
Target:
Cat. No.: HY-N5195
CAS No.: 256230-46-3
Synonyms: Nocathiacine II
Category:
Target:
Target:
Research Areas:
Tetrahydromethotrexate is a more potent folate antagonist than Methotrexate (HY-14519) in studies against certain bacteria (Streptococcus faecalis, Pediococcus erevisiae) and in animal models. Tetrahydromethotrexate is used in the research of cancer and autoimmune diseases .
Cat. No.: HY-100126R
CAS No.: 69-33-0
Synonyms: 7-Deazaadenosine (Standard)
Cat. No.: HY-151458
CAS No.: 2831498-15-6
VEGFR-2/DHFR-IN-1 (compound 8b) is an inhibitor of VEGFR-2 and DHFR with IC50s of 0.384 and 7.881 μM, respectively. VEGFR-2/DHFR-IN-1 shows good antibacterial activities against Escherichia coli, Streptococcus faecalis, Salmonella enterica, MSSA and MRSA with MIC values of 16, 16, 16, 8, and 16 μg/mL, respectively. VEGFR-2/DHFR-IN-1 exhibits good cytotoxic activities against C26, HepG2, and MCF7 cancer cell lines with IC50 values of 2.97-7.12 μM. VEGFR-2/DHFR-IN-1 can be used for the research of cancer .
Cat. No.: HY-N14392
CAS No.: 50355-68-5
Category:
Target:
Cat. No.: HY-N5196
CAS No.: 214044-52-7
Synonyms: Nocathiacine I
Category:
Target:
Cat. No.: HY-W541015
CAS No.: 89-48-5
Target:
Cat. No.: HY-111034
CAS No.: 94714-78-0
Target:
Research Areas:
CGP 31523A is a broad-spectrum aminothiazole cephalosporin. CGP 31523A exhibits potent inhibitory effects on Enterobacteriaceae, Neisseria, Haemophilus influenzae, and Streptococcus (except Enterococcus faecalis), among others. CGP 31523A can be hydrolyzed by the common Escherichia coli type Ic β-lactamase, but is stable against the Ia type enzyme. CGP 31523A is neither an effective β-lactamase inhibitor nor does it induce the production of β-lactamase. CGP 31523A can be used for studying infections caused by Gram-negative bacteria (including drug-resistant strains) .
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
